LI Ying, CAO Ailin, BAO Leilei, WANG Zhankun, QIAN Jiao. Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review[J]. Journal of Pharmaceutical Practice and Service, 2022, 40(4): 372-373, 386. doi: 10.12206/j.issn.1006-0111.202103074
Citation:
|
LI Ying, CAO Ailin, BAO Leilei, WANG Zhankun, QIAN Jiao. Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review[J]. Journal of Pharmaceutical Practice and Service, 2022, 40(4): 372-373, 386. doi: 10.12206/j.issn.1006-0111.202103074
|
Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review
- 1.
Department of Pharmacy, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
- 2.
Department of Pharmacy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China
- 3.
Department of Pharmacy, Baoding Second Central Hospital, Baoding 072750, China
- Received Date: 2021-03-25
- Rev Recd Date:
2021-06-09
Available Online:
2022-07-27
- Publish Date:
2022-07-25
-
Abstract
Objective To explore the strategies of perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation. Methods The antithrombotic therapy in one patient undergoing revision total hip arthroplasty after coronary stent implantation was analyzed with the review of related literatures. Results The patient developed non-ST segment elevated myocardial infarction due to the stop of aspirin three days before operation and no low molecular weight heparin was used. The antithrombotic treatment and prevention of venous thromboembolism were analyzed. Conclusion Antithrombotic therapy should be selected reasonably in patients undergoing revision total hip arthroplasty after coronary stent implantation.
-
References
[1]
|
周宗科, 翁习生, 曲铁兵, 等. 中国髋、膝关节置换术加速康复: 围术期管理策略专家共识[J]. 中华骨与关节外科杂志, 2016, 9(1):1-9. doi: 10.3969/j.issn.2095-9985.2016.01.001 |
[2]
|
KUMAR A, TSAI W C, TAN T S, et al. Risk of post-TKA acute myocardial infarction in patients with a history of myocardial infarction or coronary stent[J]. Clin Orthop Relat Res,2016,474(2):479-486. doi: 10.1007/s11999-015-4616-z |
[3]
|
中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志, 2016, 44(5):382-400. doi: 10.3760/cma.j.issn.0253-3758.2016.05.006 |
[4]
|
YANG Z, NI J, LONG Z, et al. Is hip fracture surgery safe for patients on antiplatelet drugs and is it necessary to delay surgery? A systematic review and meta-analysis[J]. J Orthop Surg Res,2020,15(1):105. doi: 10.1186/s13018-020-01624-7 |
[5]
|
LIPPI G, CERVELLIN G. Aspirin for thromboprophylaxis in major orthopedic surgery: old drug, new tricks? Acta Biomed,2018,89(1):31-33. |
[6]
|
WANG X, CHEN X, SUN W, et al. Very late stent thrombosis in drug-eluting stents new observations and clinical implications[J]. Cardiol Rev,2019,27(6):279-285. doi: 10.1097/CRD.0000000000000283 |
[7]
|
LEE H L, CHIU K Y, YIU K H, et al. Perioperative antithrombotic management in joint replacement surgeries[J]. Hong Kong Med J,2013,19(6):531-538. |
[8]
|
中华医学会骨科学分会. 中国骨科大手术静脉血栓栓塞症预防指南[J]. 中华骨科杂志, 2016, 36(2):65-71. doi: 10.3760/cma.j.issn.0253-2352.2016.02.001 |
[9]
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J]. 中华心血管病杂志, 2017, 45(5):359-376. doi: 10.3760/cma.j.issn.0253-3758.2017.05.003 |
[10]
|
国家卫生计生委合理用药专家委员会, 中国药师协会. 冠心病合理用药指南(第2版)[J]. 中国医学前沿杂志(电子版), 2018, 10(6):1-130. |
-
-
Proportional views
-